|
You are here |
www.wired.com | ||
| | | | |
brighterworld.mcmaster.ca
|
|
| | | | | Update, March 3, 2022: Human clinical trials for these vaccines have begun and are ongoing. This story was originally published on Dec. 7, 2021. Human . . . | |
| | | | |
news.mcmaster.ca
|
|
| | | | | Vaccines developed at McMaster target the lungs first. [...]Read More... | |
| | | | |
srconstantin.github.io
|
|
| | | | | So far I've found 6 vaccine candidates that are reporting positive results from clinical trials. | |
| | | | |
www.the-scientist.com
|
|
| | | Adenovirus vectors deliver the genetic instructions for SARS-CoV-2 antigens directly into patients' cells, provoking a robust immune response. But will pre-existing immunity from common colds take them down? | ||